Literature DB >> 17163815

Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR.

Vanessa García Moreira1, Tamara de la Cera Martínez, Emilio Gago González, Belén Prieto García, Francisco V Alvarez Menéndez.   

Abstract

BACKGROUND: Recently cell-free plasma DNA has been described as a marker of apoptosis during hemodialysis (HD), but little is known about how different dialysis membranes may contribute to this process or whether pre-HD levels are restored afterwards. Here we evaluate the influence of the dialysis membrane on cell-free plasma DNA levels and investigate the clearance of plasma circulating DNA after HD.
METHODS: Cell-free plasma DNA was measured using a real-time quantitative PCR for the beta-globin gene. Reference values for plasma DNA were established in a group of 100 healthy voluntary blood donors. Pre- and post-HD levels were also measured in 30 patients with end-stage renal disease on regular HD (52 sessions; 104 samples). The sessions lasted for 2.5-5 h. Different dialysis membranes were compared: high-flux (n=37) vs. low-flux (n=15) and polysulfone (n=42) vs. modified cellulose (n=10). To determine the time at which pre-HD levels are restored, DNA was quantified in serial plasma samples obtained from 10 of these 30 patients, just before and immediately after HD, as well as at 30, 60 and 120 min after HD.
RESULTS: Reference plasma DNA values for healthy blood donors ranged from 112 to 2452 gEq/mL (median 740 gEq/mL). Cell-free plasma DNA levels significantly increased during HD (Wilcoxon test for paired samples, p<0.0001), with increases of more than four-fold observed in 75% of the patients after HD. There was no significant linear association between the length of the HD session (between 2.5 and 5 h) and the increase in cell-free plasma DNA concentration (Pearson correlation). No significant differences were observed between different types of membranes (Mann-Whitney U-test). Plasma DNA returned to pre-HD levels by 30 min after HD, regardless of the starting concentration.
CONCLUSIONS: Plasma DNA levels significantly increase after a conventional 2.5-5-h HD session. Therefore, HD patients require special consideration for correct interpretation of plasma DNA concentrations. This parameter can be considered a reliable diagnostic tool for certain pathologies when measured at least 30 min after a HD session without further complications. The different dialysis membranes used in this study had no influence on cell-free plasma DNA concentrations, so the level of circulating DNA is not an appropriate marker of dialysis membrane biocompatibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163815     DOI: 10.1515/CCLM.2006.252

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  14 in total

Review 1.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

Review 2.  Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.

Authors:  Benjamin Levy; Zishuo I Hu; Kristen N Cordova; Sandra Close; Karen Lee; Daniel Becker
Journal:  Oncologist       Date:  2016-07-07

Review 3.  Blood-based biomarkers for the diagnosis and monitoring of gliomas.

Authors:  Marcus A Zachariah; Joao Paulo Oliveira-Costa; Bob S Carter; Shannon L Stott; Brian V Nahed
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

4.  Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum.

Authors:  Hada C Macher; Maria A Martinez-Broca; Amalia Rubio-Calvo; Cristina Leon-Garcia; Manuel Conde-Sanchez; Alzenira Costa; Elena Navarro; Juan M Guerrero
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR.

Authors:  Peng Xia; Ramin Radpour; Rebecca Zachariah; Alex Xiu Cheng Fan; Corina Kohler; Sinuhe Hahn; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  Genet Mol Biol       Date:  2009-03-01       Impact factor: 1.771

6.  Plasma cell-free DNA in patients needing mechanical ventilation.

Authors:  Marjatta Okkonen; Päivi Lakkisto; Anna-Maija Korhonen; Ilkka Parviai-nen; Matti Reinikainen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2011-08-12       Impact factor: 9.097

7.  Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.

Authors:  Fien A von Meijenfeldt; R Todd Stravitz; Jingwen Zhang; Jelle Adelmeijer; Yoh Zen; Valerie Durkalski; William M Lee; Ton Lisman
Journal:  Hepatology       Date:  2021-12-12       Impact factor: 17.298

Review 8.  NETosis provides the link between activation of neutrophils on hemodialysis membrane and comorbidities in dialyzed patients.

Authors:  Marie Korabecna; Vladimir Tesar
Journal:  Inflamm Res       Date:  2016-11-24       Impact factor: 4.575

9.  Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.

Authors:  Els M Gielis; Charlie Beirnaert; Amélie Dendooven; Pieter Meysman; Kris Laukens; Joachim De Schrijver; Steven Van Laecke; Wim Van Biesen; Marie-Paule Emonds; Benedicte Y De Winter; Jean-Louis Bosmans; Jurgen Del Favero; Daniel Abramowicz; Kristien J Ledeganck
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

10.  High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.

Authors:  Erik Forsblom; Janne Aittoniemi; Eeva Ruotsalainen; Visa Helmijoki; Reetta Huttunen; Juulia Jylhävä; Mikko Hurme; Asko Järvinen
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.